These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10524573)

  • 1. Comparison of two thyroglobulin immunoradiometric assays on the basis of comprehensive imaging in differentiated thyroid carcinoma.
    Mikosch P; Gallowitsch HJ; Kresnik E; Unterweger O; Gomez I; Lind P
    Thyroid; 1999 Sep; 9(9):933-41. PubMed ID: 10524573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-sensitive 2nd generation thyroglobulin immunoradiometric assay. Clinical application in differentiated thyroid cancer management.
    Giovanella L; Ceriani L; Garancini S
    Q J Nucl Med; 2002 Dec; 46(4):319-22. PubMed ID: 12411872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of efficacy of various methods of thyroglobulin measurements in differentiated thyroid cancer].
    Czernik E; Deja R; Gubała E; Kukulska A; Turska M; Dabrowska-Czuba E; Bartnikowa W; Jarzab B
    Wiad Lek; 2001; 54 Suppl 1():339-48. PubMed ID: 12182046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma.
    Giovanella L; Maffioli M; Ceriani L; De Palma D; Spriano G
    Clin Chem Lab Med; 2009; 47(8):1001-4. PubMed ID: 19589104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of two methods to assay thyroglobulin serum concentrations in patients with differentiated thyroid carcinomas.
    Ferrari L; Seregni E; Aliberti G; Martinetti A; Pallotti F; Villano C; Lucignani G; Bombardieri E
    Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):237-42. PubMed ID: 15499298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
    Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?
    Mariotti S; Barbesino G; Caturegli P; Marinó M; Manetti L; Pacini F; Centoni R; Pinchera A
    J Clin Endocrinol Metab; 1995 Feb; 80(2):468-72. PubMed ID: 7852506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement.
    Spencer CA; LoPresti JS; Fatemi S; Nicoloff JT
    Thyroid; 1999 May; 9(5):435-41. PubMed ID: 10365673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma].
    Zöphel K; Wunderlich G; Liepach U; Koch R; Bredow J; Franke WG
    Nuklearmedizin; 2001 Oct; 40(5):155-63. PubMed ID: 11727628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of a new thyroglobulin immunoradiometric assay in the follow-up of differentiated thyroid carcinoma].
    Sahlmann CO; Schreivogel I; Angerstein C; Siefker U; Lehmann K; Altenvoerde G; Hüfner M; Meller J
    Nuklearmedizin; 2003; 42(2):71-7. PubMed ID: 12695789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
    Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
    Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the influence of thyroglobulin (Tg) autoantibodies and other interfering factors on the use of serum Tg as tumor marker in differentiated thyroid carcinoma.
    Schaadt B; Feldt-Rasmussen U; Rasmusson B; Tørring H; Foder B; Jørgensen K; Hansen HS
    Thyroid; 1995 Jun; 5(3):165-70. PubMed ID: 7580263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum thyroglobulin measurements with a high sensitivity enzyme-linked immunosorbent assay: is there a clinical benefit in patients with differentiated thyroid carcinoma?
    Zöphel K; Wunderlich G; Smith BR
    Thyroid; 2003 Sep; 13(9):861-5. PubMed ID: 14588100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High sensitive thyroglobulin assay on thyroxine therapy: can it avoid stimulation test in low and high risk differentiated thyroid carcinoma patients?
    Trimboli P; La Torre D; Ceriani L; Condorelli E; Laurenti O; Romanelli F; Ventura C; Signore A; Valabrega S; Giovanella L
    Horm Metab Res; 2013 Sep; 45(9):664-8. PubMed ID: 23720229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high-sensitivity enzyme-linked immunosorbent assay for serum thyroglobulin.
    Wunderlich G; Zöphel K; Crook L; Smith S; Smith BR; Franke WG
    Thyroid; 2001 Sep; 11(9):819-24. PubMed ID: 11575850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new immunoradiometric assay (IRMA) system for thyroglobulin measurement in the follow-up of thyroid cancer patients.
    Schlumberger M; Fragu P; Gardet P; Lumbroso J; Violot D; Parmentier C
    Eur J Nucl Med; 1991; 18(3):153-7. PubMed ID: 2040337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-sensitivity human thyroglobulin (hTG) immunoradiometric assay in the follow-up of patients with differentiated thyroid cancer.
    Giovanella L; Ceriani L
    Clin Chem Lab Med; 2002 May; 40(5):480-4. PubMed ID: 12113292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical aspects of immunoradiometric thyroglobulin assays.
    Ferrari L; Biancolini D; Seregni E; Aliberti G; Martinetti A; Villano C; Pallotti F; Chiesa C; Bombardieri E
    Tumori; 2003; 89(5):537-9. PubMed ID: 14870780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Continously increasing sensitivity in thyroid cancer aftercare in the course of three generations of thyroglobulin IMAs].
    Görges R; Brandt-Mainz K; Freudenberg L; Frilling A; Grimm W; Bockisch A
    Nuklearmedizin; 2003 Aug; 42(4):157-66. PubMed ID: 12937694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma.
    Wang PW; Wang ST; Liu RT; Chien WY; Tung SC; Lu YC; Chen HY; Lee CH
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4549-53. PubMed ID: 10599717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.